Alpha 2.0
Login Register
» Authors » Vilberg Johannesson

Vilberg Johannesson

Explore the profile of Vilberg Johannesson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 18
Followers 0
Related Specialties
Oncology
Radiology
Top 10 Co-Authors
Elisabeth Kjellen
Adalsteinn Gunnlaugsson
Per Nilsson
Elinore Wieslander
Goran Ahlgren
Ulrika Bitzen
Ola Bratt
Eva Brun
Montserrat Pazos
Klaus Seiersen
Published In
Clin Transl Radiat Oncol
Tech Innov Patient Support Radiat Oncol
Phys Imaging Radiat Oncol
Adv Radiat Oncol
Radiother Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Ultrahypofractionated Radiation Therapy for Prostate Cancer Including Seminal Vesicles in the Target Volume: A Treatment-planning Study Based on the HYPO-RT-PC Fractionation Schedule
Wieslander E, Johannesson V, Nilsson P, Kjellen E, Gunnlaugsson A
Adv Radiat Oncol . 2024 Jun; 9(7):101531. PMID: 38883997
Purpose: Ultrahypofractionated (UHF) radiation therapy (RT) has become a treatment alternative for patients with localized prostate cancer. In more advanced cases, seminal vesicles (SVs) are routinely included in the target...
2.
Dose-volume relationships of planned versus estimated delivered radiation doses to pelvic organs at risk and side effects in patients treated with salvage radiotherapy for recurrent prostate cancer
Johannesson V, Gunnlaugsson A, Nilsson P, Brynolfsson P, Kjellen E, Wieslander E
Tech Innov Patient Support Radiat Oncol . 2024 Jan; 29:100231. PMID: 38192583
Purpose: To investigate estimated delivered dose distributions using weekly cone-beam computed tomography (CBCT) scans for pelvic organs at risk (OARs) in salvage radiotherapy (SRT) after radical prostatectomy. Furthermore, to compare...
3.
A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and Ga-PSMA-PET for biochemical relapse after radical prostatectomy - The PROPER 1 trial
Gunnlaugsson A, Johannesson V, Wieslander E, Brun E, Bitzen U, Stahl O, et al.
Clin Transl Radiat Oncol . 2022 Jul; 36:77-82. PMID: 35873652
Background And Purpose: The treatment of biochemical recurrence (BCR) after prostatectomy is challenging as the site of the recurrence is often undetectable. Our aim was to test a personalised treatment...
4.
ESTRO ACROP and SIOPE recommendations for myeloablative Total Body Irradiation in children
Hoeben B, Pazos M, Seravalli E, Bosman M, Losert C, Albert M, et al.
Radiother Oncol . 2022 Jun; 173:119-133. PMID: 35661674
Background And Purpose: Myeloablative Total Body Irradiation (TBI) is an important modality in conditioning for allogeneic hematopoietic stem cell transplantation (HSCT), especially in children with high-risk acute lymphoblastic leukemia (ALL)....
5.
Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer
Johannesson V, Wieslander E, Nilsson P, Brun E, Bitzen U, Ahlgren G, et al.
Phys Imaging Radiat Oncol . 2021 Jul; 18:5-10. PMID: 34258401
Background: Treatment adaptation based on tumour biomarker response during radiotherapy of prostate cancer, could be used for both escalation and de-escalation of radiation doses and volumes. To execute an adaptation...
6.
PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome - 5 year follow-up of a prospective observational study
Gunnlaugsson A, Kjellen E, Bratt O, Ahlgren G, Johannesson V, Blom R, et al.
Clin Transl Radiat Oncol . 2020 Jul; 24:23-28. PMID: 32613088
Background And Purpose: Biochemical recurrence after prostatectomy is commonly treated with salvage radiotherapy (SRT). In this prospective observational study we investigated the PSA decay rate, determined by predefined serial PSA...